Company Overview
About Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, activity, and manufacturability. Founded in 2021 and headquartered in Amsterdam with teams in San Francisco, Cradle raised approximately $24 million and targets biopharmaceutical, agricultural, and industrial biotechnology companies that need to engineer proteins with specific functional properties.
Business Model & Competitive Advantage
Cradle's platform combines large language models trained on protein sequence data (similar to how LLMs learn from text) with laboratory robotics integration to enable active learning workflows — the AI suggests protein variants to test, laboratory results are fed back to improve the model, and the cycle repeats until optimal variants are identified. This automated design-build-test cycle dramatically reduces the time and cost compared to traditional trial-and-error protein engineering.
Competitive Landscape 2025–2026
In 2025, Cradle competes in the AI-powered protein engineering market alongside Absci, EvolutionaryScale (ESM protein language model), and Generate Biomedicines for therapeutic applications, and with enzyme engineering companies like Codexis for industrial applications. The protein design AI space has accelerated significantly with AlphaFold 2's publication (structure prediction) and subsequent protein engineering tools. Cradle's focus on optimizing proteins for specific functional properties (rather than just predicting structure) addresses a critical need in drug development and industrial biotech. The 2025 strategy includes expanding platform coverage to antibody engineering and expanding enterprise deals with large biopharma companies for continuous protein optimization programs.
Recent Activity
View all →Key Differentiators
Strong Challenger
Cradle is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Regeneron
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized m
Vivtex
Vivtex is an MIT Langer Laboratory spinout that has developed a drug delivery platform enabling oral administration of biologics — proteins, peptides, and other large molecules — that have historicall
Compare Cradle with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Cradle? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Cradle Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Cradle vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →